Updates

Alemtuzumab as part of conditioning therapy for Graft-Vs-Host Disease in children and young adults

05/05/2021

Research
min. read

Topics

Read

Full media story at www.hematologyadvisor.com

Related Stories

Research Mar 23, 2022

New Study Shows “Living Drug” Can Provide a Lasting Cure for Cancer

leaps.org
Research Aug 26, 2025

Study reveals how prolonged exposure to food orders can suppress appetites

Research Aug 25, 2025

Administering CAR T-cell therapy to younger patients requires ‘ongoing and open’ relationships

healio.com
Research Aug 21, 2025

2025 Cain Collaborative Pilot Grant Application Now Open

Research Aug 21, 2025

A Powerful New Tool to Solve Complex Diseases and Deliver Precision Medicine

Research Jul 07, 2025

Changes in the blood could protect against Alzheimer’s disease

See more results